Literature DB >> 11742504

ALA and ALA hexyl ester-induced porphyrin synthesis in chemically induced skin tumours: the role of different vehicles on improving photosensitization.

A Casas1, C Perotti, H Fukuda, L Rogers, A R Butler, A Batlle.   

Abstract

Exogenous administration of 5-aminolevulinic acid (ALA) is becoming widely used to enhance the endogenous synthesis of Protoporphyrin IX (PpIX) in photodynamic therapy. We analysed porphyrin formation in chemically induced squamous papillomas, after topical application of ALA and ALA hexyl ester (He-ALA) administered in different formulations, as well as the pattern of distribution in the internal organs, and the synthesis of porphyrins in distant tumoural and normal skins. A lotion formulation containing DMSO and ethanol was the best vehicle for topical ALA delivery to papillomas, whereas cream was the most efficient formulation for He-ALA application. Similar porphyrin concentration can be accumulated in the skin tumours employing either ALA or He-ALA delivered in their optimal formulations. The use of cream as a vehicle of both ALA and He-ALA, induces highest porphyrin tumour/normal skin ratios. The main advantage of using He-ALA is that porphyrins synthesized from the ester are more confined to the site of application, thus inducing low porphyrin levels in normal skin, liver, blood and spleen, as well as in papillomas distant from the point of application, independently on the vehicle employed, so reducing potential side effects of photodynamic therapy. (c) 2001 Cancer Research Campaign

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11742504      PMCID: PMC2363985          DOI: 10.1054/bjoc.2001.2156

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin.

Authors:  Q Peng; J Moan; T Warloe; V Iani; H B Steen; A Bjørseth; J M Nesland
Journal:  J Photochem Photobiol B       Date:  1996-06       Impact factor: 6.252

2.  Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic acid to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum.

Authors:  J T van den Akker; V Iani; W M Star; H J Sterenborg; J Moan
Journal:  Photochem Photobiol       Date:  2000-11       Impact factor: 3.421

3.  Treatment of psoriasis by topical photodynamic therapy with polychromatic light.

Authors:  W H Boehncke; W Sterry; R Kaufmann
Journal:  Lancet       Date:  1994-03-26       Impact factor: 79.321

4.  Protoporphyrin IX fluorescence kinetics and localization after topical application of ALA pentyl ester and ALA on hairless mouse skin with UVB-induced early skin cancer.

Authors:  J T van den Akker; H S de Bruijn; G M Beijersbergen van Henegouwen; W M Star; H J Sterenborg
Journal:  Photochem Photobiol       Date:  2000-09       Impact factor: 3.421

5.  Tumour-localizing properties of porphyrins. In vivo studies using free and liposome encapsulated aminolevulinic acid.

Authors:  H Fukuda; S Paredes; A M Batlle
Journal:  Comp Biochem Physiol B       Date:  1992-06

6.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience.

Authors:  J C Kennedy; R H Pottier; D C Pross
Journal:  J Photochem Photobiol B       Date:  1990-06       Impact factor: 6.252

7.  Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma.

Authors:  Q Peng; T Warloe; J Moan; H Heyerdahl; H B Steen; J M Nesland; K E Giercksky
Journal:  Photochem Photobiol       Date:  1995-11       Impact factor: 3.421

8.  Comparative effect of ALA derivatives on protoporphyrin IX production in human and rat skin organ cultures.

Authors:  A Casas; A M Batlle; A R Butler; D Robertson; E H Brown; A MacRobert; P A Riley
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

9.  Tissue distribution and kinetics of endogenous porphyrins synthesized after topical application of ALA in different vehicles.

Authors:  A Casas; H Fukuda; A M Batlle
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

10.  Approach to risk assessment for genotoxic carcinogens based on data from the mouse skin initiation-promotion model.

Authors:  F Burns; R Albert; B Altshuler; E Morris
Journal:  Environ Health Perspect       Date:  1983-04       Impact factor: 9.031

View more
  3 in total

1.  In vitro metabolism of 5-ALA esters derivatives in hairless mice skin homogenate and in vivo PpIX accumulation studies.

Authors:  Fernanda Scarmato De Rosa; Renata Fonseca Vianna Lopez; José Antônio Thomazine; Antônio Cláudio Tedesco; Norbert Lange; Maria Vitória Lopes Badra Bentley
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

2.  Topical application of ALA and ALA hexyl ester on a subcutaneous murine mammary adenocarcinoma: tissue distribution.

Authors:  C Perotti; A Casas; H Fukuda; P Sacca; A Batlle
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

3.  Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies.

Authors:  C Perotti; H Fukuda; G DiVenosa; A J MacRobert; A Batlle; A Casas
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.